Tag : genome sequencing

SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases Proceeds to fund first-in-human trials of breakthrough gene therapy products, SPVN06 and SPVN20, and advance CRISPR-based genome editing portfolio...

Debiopharm Innovation Fund strategically invests in Whitelab Genomics’ mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in...

An expert from Invitae and Ambry Genetics, U.S. genome analysis companies EDGC states, “We will expand the overseas genome analysis market and advance into the...

Presented during the ESMO Congress 2022, HER2DX®️ predicts the response of trastuzumab, pertuzumab and letrozole in patients with HER2+ HR+ breast cancer. This is the first...

Singulator™ 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. S2 Genomics, Inc. today announced that it has...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced promotions and organizational...

Armonica Technologies, Inc., a biotechnology company developing a novel DNA sequencing system based on single molecule spectroscopy, announced that the company has been awarded a...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is initiating a new business unit to drive innovation and product development within the area of...

Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth opportunity Services at launch include rapid turnaround sequencing of clinical...

Ancestry®, the global leader in family history and consumer genomics, today announced it has expanded AncestryDNA® to 54 new markets across North America, South America,...